Harbor Diversified, Inc.
| OTC Markets: HRBR
Harbor Diversified, Inc. is a development stage pharmaceutical company engaged in the discovery, development and commercialization of products for the treatment of diseases related to aging. Its technology development efforts are focused on a series of adrenal steroid hormones and synthetic analogs that may be useful in treating a variety of medical conditions. Harbor Diversified focuses on two clinical development products, Apoptone and Triolex. The company was founded on August 15, 1994 and is headquartered in San Diego, CA.